Expression Of Cox-2 In Non- Liver Diseases
Keywords:
COX-2,, liver disease, liver cancer.Abstract
To determine the frequency of liver diseases and evaluate the expression of COX-2 in non-neoplastic
and neoplastic liver lesions.
Methodology: This cross sectional study is based on the analysis of liver biopsies received at department of
pathology, BMSI, JPMC from 1st January 2010 to 31st December 2012. Approximately 71 cases of formalin fixed liver
tissue biopsies were selected and analyzed for morphological features, grading and results of
immunohistochemical staining for COX-2. The data feeding and analysis were on computer package SPSS
(Statistical Packages of Social Sciences) version 16.0. In all statistical analysis only p-value <0.05 was considered
significant.
Results: The most commonly encountered liver disease , out of the total 288 cases ,was chronic liver disease
(CLD) including 255 cases (88.54%) out of these 12(4.17%) showed full- fledged cirrhotic nodule. Mean age was
33 yrs. for chronic liver disease. Male female ratio was 1.6:1 for CLD while for hepatocellular carcinoma and bile
duct carcinoma M/F ratio was 2.8:1. The etiological distribution of 255 cases of CLD cases revealing that hepatitis
C is the most common cause of chronic hepatitis accounting for 70% of cases. On immunostaining using COX-2
antibody for CLD with mild inflammatory grade cases, only 14.2% showed strong staining and all the 19 HCC
and bile duct carcinoma 78.94% displayed strong positivity.
Conclusion: There is progressive increase in staining expression of COX-2 in non-neoplastic and neoplastic
liver lesions. An early inhibition of COX-2 via selective COX-2 inhibitors may prevent further exacerbation of
disease.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Mubashira Hashmi, Shahnaz Imdad Kehar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
